English   中文
展开

奇可药业在线客服

  • 销售一部 点击这里给我发消息
  • 销售二部 点击这里给我发消息
  • 销售三部 点击这里给我发消息

R&D &MAH

R&D center

We always pay attention to our technology .We have built an R&D center which covers 1500 ㎡ in Jiangsu life Science& Technology Innovation Park. Our center is divided into R&D department and Pilot scale department, which can complete pilot scale requirements. The center has a team of experienced, energetic, and equipped with advanced organic synthesis and analysis of testing instruments and equipment, research and development center management system through the ISO9001 quality certification.
Our R&D center is focused on targeted anti-tumor products, cardiovascular products, and anti-diabetes products. Our main products are:
(1)Antitumor drug— Imatinib、Gefitinib、Erlotinib、Dasatinib、Lapatinib、Sunitinib、Nilotinib、Sorafenib 、Vandetanib、Axitinib、Afatinib、Pazopanib、Ibrutinib、 Lenvatinib、Palbociclib、Osimertinib、Crizotinib、Vemurafenib、Cabozantinib、Bosutinib、Regorafenib、Ponatinib、 Trametinib、Ceritinib、Nintedanib、Lenalidomide、Bendamostatin .ect;
(2)Anticardio-cerebrovascular drugs.---Apixaban, Rivaroxaban,  Prasugrel, Ticagrelor, Dabigatran , Ezetimibe and so on.
(3)Anti-diabetic drugs--
DPP-4:Alogliptin, Linagliptin, Vildagliptin, Sitagliptin, Teneligliptin, Saxagliptin, etc.
SGLT-2:Dapagliflozin、Canagliflozin、Empagliflozin、Ipragliflozin etc.

 

Contact Us

  • Sales Department I:
    Contact:Kirsten Jiang
    TEL:+86-025-84351604/13057662806
    QQ:在线联系
  • Sales Department II
    Contact:Dannie Lee
    TEL:+86-025-84352267/15150674956
    QQ:在线联系
  • Sales Department III
    Contact:Ms.zhu
    TEL:+86-025-84351676/13809032362
    QQ:在线联系
Copyright 2016 Nanjing CHICO Pharmaceutical Co., Ltd. All rights reserved. Supported by www.hxchem.net